Emerging data suggest Retatrutide , a dual activator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , may represent a promising step forward for weight loss . Preliminary patient tests have shown impressive losses in body fat , possibly outperforming other weight-loss treatments. Nevertheless , additional assessm